U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO Profiles

Items: 1 to 20 of 339

1.
Bortezomib potentially inhibits cellular growth of vascular endothelial cells through suppression of G2/M transition
Daisuke Tamura, Tokuzo Arao, Kaoru Tanaka, Hiroyasu Kaneda, Kazuko Matsumoto, Kanae Kudo, Keiichi Aomatsu, Yoshihiko Fujita, Takashi Watanabe, Nagahiro Saijo, Yoshikazu Kotani, Yoshihiro Nishimura, Kazuto Nishio
Cancer Sci. 2010 Jun; 101(6): 1403–1408. Published online 2010 Mar 15. doi: 10.1111/j.1349-7006.2010.01544.x
PMCID:
PMC11159993
AbstractArticlePDF–429K
2.
Nuclear cyclin B1 in human breast carcinoma as a potent prognostic factor
Takashi Suzuki, Tomohiro Urano, Yasuhiro Miki, Takuya Moriya, Jun‐ichi Akahira, Takanori Ishida, Kuniko Horie, Satoshi Inoue, Hironobu Sasano
Cancer Sci. 2007 May; 98(5): 644–651. Published online 2007 Mar 14. doi: 10.1111/j.1349-7006.2007.00444.x
PMCID:
PMC11159733
AbstractArticlePDF–418K
3.
KCNN1 promotes proliferation and metastasis of breast cancer via ERLIN2-mediated stabilization and K63-dependent ubiquitination of Cyclin B1
Bin Xiao, Qin Xiang, Zihua Deng, Daxiang Chen, Shunhong Wu, Yanxia Zhang, Yaru Liang, Shi Wei, Guoqing Luo, Linhai Li
Carcinogenesis. 2023 Dec; 44(12): 809–823. Published online 2023 Oct 13. doi: 10.1093/carcin/bgad070
PMCID:
PMC10818095
AbstractArticlePDF–44M
4.
Prognostic value of cyclin B1 and cyclin B2 expression in breast cancer: A systematic review and updated meta-analysis
Jeongwan Kang, Hera Jung, Hyunchul Kim
Medicine (Baltimore) 2024 Jan 19; 103(3): e37016. Published online 2024 Jan 19. doi: 10.1097/MD.0000000000037016
PMCID:
PMC10798710
AbstractArticlePDF–1.2M
5.
Hsa-circ-0006091 modulates the proliferation of hepatocellular carcinoma via the miR-622/CCNB1 axis
Xiaofeng ZHAO, Ling HE
Turk J Med Sci. 2023; 53(5): 1367–1378. Published online 2023 May 31. doi: 10.55730/1300-0144.5703
PMCID:
PMC10763780
AbstractArticlePDF–4.3M
6.
A pancancer analysis of the oncogenic role of cyclin B1 (CCNB1) in human tumors
Peng Dai, Lecai Xiong, Yanhong Wei, Xiaoyan Wei, Xuefeng Zhou, Jinping Zhao, Hexiao Tang
Sci Rep. 2023; 13: 16226. Published online 2023 Sep 27. doi: 10.1038/s41598-023-42801-y
PMCID:
PMC10533567
AbstractArticlePDF–8.5M
7.
The adapter protein FADD provides an alternate pathway for entry into the cell cycle by regulating APC/C-Cdh1 E3 ubiquitin ligase activity
Sahezeel Awadia, Merna Sitto, Sundaresh Ram, Wenbin Ji, Yajing Liu, Raheema Damani, Dipankar Ray, Theodore S. Lawrence, Craig J. Galban, Steven D. Cappell, Alnawaz Rehemtulla
J Biol Chem. 2023 Jun; 299(6): 104786. Published online 2023 May 4. doi: 10.1016/j.jbc.2023.104786
PMCID:
PMC10248554
AbstractArticlePDF–6.8M
8.
TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing
Engin Demirdizen, Ruslan Al-Ali, Ashwin Narayanan, Xueyuan Sun, Julianna Patricia Varga, Bianca Steffl, Manuela Brom, Damir Krunic, Claudia Schmidt, Gabriele Schmidt, Felix Bestvater, Julian Taranda, Şevin Turcan
Neuro Oncol. 2023 Jun; 25(6): 1031–1043. Published online 2022 Nov 22. doi: 10.1093/neuonc/noac233
PMCID:
PMC10237422
AbstractArticlePDF–23M
9.
Molecular mechanisms for activation of the 26S proteasome
Donghoon Lee, Yanan Zhu, Louis Colson, Xiaorong Wang, Siyi Chen, Emre Tkacik, Lan Huang, Qi Ouyang, Alfred L. Goldberg, Ying Lu
Version 1. bioRxiv. Preprint. 2023 May 10. doi: 10.1101/2023.05.09.540094
Published in:
Mol Cell. 2023 Aug 17; 83(16): 2959–2975.e7.
PMCID:
PMC10197607
AbstractArticle
10.
Expression significance of Emi1, UBCH10 and CyclinB1 in esophageal squamous cell carcinoma
Hui Li, Chenbo Yang, Kuisheng Chen, Miaomiao Sun
Pathol Oncol Res. 2023; 29: 1611081. Published online 2023 Apr 24. doi: 10.3389/pore.2023.1611081
PMCID:
PMC10164988
AbstractArticlePDF–3.1M
11.
Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity
Martin Golkowski, Andrea Lius, Tanmay Sapre, Ho-Tak Lau, Taylor Moreno, Dustin J. Maly, Shao-En Ong
Mol Cell. Author manuscript; available in PMC 2023 Apr 4.
Published in final edited form as: Mol Cell. 2023 Mar 2; 83(5): 803–818.e8. Published online 2023 Feb 2. doi: 10.1016/j.molcel.2023.01.015
PMCID:
PMC10072906
AbstractArticlePDF–4.2M
12.
The clinical significance of cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion development
Abrar I. Aljohani, Michael S. Toss, Andrew R. Green, Emad A. Rakha
Breast Cancer Res Treat. 2023; 198(3): 423–435. Published online 2022 Nov 22. doi: 10.1007/s10549-022-06801-2
PMCID:
PMC10036284
AbstractArticlePDF–1.2M
13.
HN1 Is Enriched in the S-Phase, Phosphorylated in Mitosis, and Contributes to Cyclin B1 Degradation in Prostate Cancer Cells
Aadil Javed, Gülseren Özduman, Lokman Varışlı, Bilge Esin Öztürk, Kemal Sami Korkmaz
Biology (Basel) 2023 Feb; 12(2): 189. Published online 2023 Jan 26. doi: 10.3390/biology12020189
PMCID:
PMC9952942
AbstractArticlePDF–3.5M
14.
Proximity Labeling Reveals Spatial Regulation of the Anaphase-Promoting Complex/Cyclosome by a Microtubule Adaptor
Xiaofu Cao, Adnan Shami Shah, Ethan J. Sanford, Marcus B. Smolka, Jeremy M. Baskin
ACS Chem Biol. Author manuscript; available in PMC 2023 Sep 16.
Published in final edited form as: ACS Chem Biol. 2022 Sep 16; 17(9): 2605–2618. Published online 2022 Aug 11. doi: 10.1021/acschembio.2c00527
PMCID:
PMC9933862
AbstractArticlePDF–2.5M
15.
The histone acetyltransferase KAT6A is recruited to unmethylated CpG islands via a DNA binding winged helix domain
Lisa Marie Weber, Yulin Jia, Bastian Stielow, Stephen S Gisselbrecht, Yinghua Cao, Yanpeng Ren, Iris Rohner, Jessica King, Elisabeth Rothman, Sabrina Fischer, Clara Simon, Ignasi Forné, Andrea Nist, Thorsten Stiewe, Martha L Bulyk, Zhanxin Wang, Robert Liefke
Nucleic Acids Res. 2023 Jan 25; 51(2): 574–594. Published online 2022 Dec 20. doi: 10.1093/nar/gkac1188
PMCID:
PMC9881136
AbstractArticlePDF–4.4M
16.
CCNB1 and AURKA are critical genes for prostate cancer progression and castration-resistant prostate cancer resistant to vinblastine
Xi Chen, Junjie Ma, Xin’an Wang, Tong Zi, Duocheng Qian, Chao Li, Chengdang Xu
Front Endocrinol (Lausanne) 2022; 13: 1106175. Published online 2022 Dec 19. doi: 10.3389/fendo.2022.1106175
PMCID:
PMC9806262
AbstractArticlePDF–3.8M
17.
A whole genome CRISPR screen identifies AHR loss as a mechanism of resistance to a PARP7 inhibitor
Huadong Chen, Morgan E. Diolaiti, Patrick C. O’Leary, Ajda Rojc, Nevan J. Krogan, Minkyu Kim, Alan Ashworth
Mol Cancer Ther. Author manuscript; available in PMC 2023 Jan 5.
Published in final edited form as: Mol Cancer Ther. 2022 Jul 5; 21(7): 1076–1089. doi: 10.1158/1535-7163.MCT-21-0841
PMCID:
PMC9769698
AbstractArticlePDF–2.7M
18.
A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation
Yulemi Gonzalez Quesada, Luc DesGroseillers
Int J Mol Sci. 2022 Oct; 23(19): 11588. Published online 2022 Sep 30. doi: 10.3390/ijms231911588
PMCID:
PMC9569955
AbstractArticlePDF–2.1M
19.
Identification and verification of CCNB1 as a potential prognostic biomarker by comprehensive analysis
Yinzhen Zeng, Rong Fan
Sci Rep. 2022; 12: 16153. Published online 2022 Sep 27. doi: 10.1038/s41598-022-20615-8
PMCID:
PMC9515086
AbstractArticlePDF–6.2M
20.
Structural Insights into the Phosphorylation-Enhanced Deubiquitinating Activity of UCHL3 and Ubiquitin Chain Cleavage Preference Analysis
Yujing Ren, Beiming Yu, Lihui Zhou, Feng Wang, Yanfeng Wang
Int J Mol Sci. 2022 Sep; 23(18): 10789. Published online 2022 Sep 15. doi: 10.3390/ijms231810789
PMCID:
PMC9501053
AbstractArticlePDF–2.1M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center